Skip to main content

Table 4 Cox cause-specific hazard ratios (csHR), subdistribution hazard ratios (subHR), and associated 95% confidence intervals for evaluating the treatment effect; adjusted for nodal status and both tumour size.

From: Analysis and design of randomised clinical trials involving competing risks endpoints

  Adjusted for nodal status and tumour size
Competing event csHR subHR
M: Distant metastasis 0.39 (0.22 - 0.71) 0.42 (0.23 - 0.79)
R: Loco-regional recurrence 0.69 (0.27 - 1.79) 0.81 (0.30 - 2.17)